[1] PATTNI B S, CHUPIN V V, TORCHILIN V P. New developments in liposomal drug delivery[J]. Chem Rev,2015,115(19):10938-10966. doi:  10.1021/acs.chemrev.5b00046
[2] PALIWAL S R, PALIWAL R, AGRAWAL G P, et al. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin[J]. J Liposome Res,2016,26(4):276-287. doi:  10.3109/08982104.2015.1117489
[3] WILHELM S, TAVARES A J, DAI Q, et al. Analysis of nanoparticle delivery to tumours[J]. Nat Rev Mater,2016,1(5):16014. doi:  10.1038/natrevmats.2016.14
[4] PRABHAKAR U, MAEDA H, JAIN R K, et al. Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology[J]. Cancer Res,2013,73(8):2412-2417. doi:  10.1158/0008-5472.CAN-12-4561
[5] LI M, SHI K, TANG X, et al. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma[J]. Eur J Pharm Sci,2018,124:240-248. doi:  10.1016/j.ejps.2018.07.055
[6] XIA X L, YANG X Y, HUANG P, et al. ROS-responsive nanoparticles formed from RGD-epothilone B conjugate for targeted cancer therapy[J]. ACS Appl Mater Interfaces,2020,12(16):18301-18308. doi:  10.1021/acsami.0c00650
[7] DE LA RICA R, AILI D, STEVENS M M. Enzyme-responsive nanoparticles for drug release and diagnostics[J]. Adv Drug Deliv Rev,2012,64(11):967-978. doi:  10.1016/j.addr.2012.01.002
[8] YU F, WU H, TANG Y, et al. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system[J]. Int J Pharm,2018,536(1):11-20. doi:  10.1016/j.ijpharm.2017.11.025
[9] PODARU G, OGDEN S, BAXTER A, et al. Pulsed magnetic field induced fast drug release from magneto liposomes via ultrasound generation[J]. J Phys Chem B,2014,118(40):11715-11722. doi:  10.1021/jp5022278
[10] LUO D, LI N, CARTER K A, et al. Rapid light-triggered drug release in liposomes containing small amounts of unsaturated and porphyrin-phospholipids[J]. Small,2016,12(22):3039-3047. doi:  10.1002/smll.201503966
[11] ELOY J O, PETRILLI R, TREVIZAN L N F, et al. Immunoliposomes: a review on functionalization strategies and targets for drug delivery[J]. Colloids Surf B Biointerfaces,2017,159:454-467. doi:  10.1016/j.colsurfb.2017.07.085
[12] BRIEGER K, SCHIAVONE S, MILLER F J, et al. Reactive oxygen species: from health to disease[J]. Swiss Med Wkly,2012,142:w13659.
[13] INOUE M, SATO E F, NISHIKAWA M, et al. Mitochondrial generation of reactive oxygen species and its role in aerobic life[J]. Curr Med Chem,2003,10(23):2495-2505. doi:  10.2174/0929867033456477
[14] LIOU G Y, STORZ P. Reactive oxygen species in cancer[J]. Free Radic Res,2010,44(5):479-496. doi:  10.3109/10715761003667554
[15] MANDA G, ISVORANU G, COMANESCU M V, et al. The redox biology network in cancer pathophysiology and therapeutics[J]. Redox Biol,2015,5:347-357. doi:  10.1016/j.redox.2015.06.014
[16] PANIERI E, SANTORO M M. ROS homeostasis and metabolism: a dangerous liason in cancer cells[J]. Cell Death Dis,2016,7(6):e2253. doi:  10.1038/cddis.2016.105
[17] SZATROWSKI T P, NATHAN C F. Production of large amounts of hydrogen peroxide by human tumor cells[J]. Cancer Res,1991,51(3):794-798.
[18] CHIANG Y T, YEN Y W, LO C L. Reactive oxygen species and glutathione dual redox-responsive micelles for selective cytotoxicity of cancer[J]. Biomaterials,2015,61:150-161. doi:  10.1016/j.biomaterials.2015.05.007
[19] DU Y, HE W, XIA Q, et al. Thioether phosphatidylcholine liposomes: a novel ROS-responsive platform for drug delivery[J]. ACS Appl Mater Interfaces,2019,11(41):37411-37420. doi:  10.1021/acsami.9b08901
[20] LOU J C, BEST M D. Reactive oxygen species-responsive liposomes via boronate-caged phosphatidylethanolamine[J]. Bioconjugate Chem,2020,31(9):2220-2230. doi:  10.1021/acs.bioconjchem.0c00397
[21] NOYHOUZER T, L’HOMME C, BEAULIEU I, et al. Ferrocene-modified phospholipid: an innovative precursor for redox-triggered drug delivery vesicles selective to cancer cells[J]. Langmuir,2016,32(17):4169-4178. doi:  10.1021/acs.langmuir.6b00511
[22] CLEGG A D, REES N V, KLYMENKO O V, et al. Marcus theory of outer-sphere heterogeneous electron transfer reactions: High precision steady-state measurements of the standard electrochemical rate constant for ferrocene derivatives in alkyl cyanide solvents[J]. J Electroanal Chem,2005,580(1):78-86. doi:  10.1016/j.jelechem.2005.03.013
[23] 卢光照, 侯 成, 钟延强, 等. 活性氧自由基响应给药系统研究进展[J]. 药学学报, 2017, 52(2):206-213. doi:  10.16438/j.0513-4870.2016-0923
[24] FUSE T, TAGAMI T, TANE M, et al. Effective light-triggered contents release from helper lipid-incorporated liposomes co-encapsulating gemcitabine and a water-soluble photosensitizer[J]. Int J Pharm,2018,540(1-2):50-56. doi:  10.1016/j.ijpharm.2018.01.040
[25] ZHAO Z H, WANG W Q, LI C X, et al. Reactive oxygen species–activatable liposomes regulating hypoxic tumor microenvironment for synergistic photo/chemodynamic therapies[J]. Adv Funct Mater,2019,29(44):1905013. doi:  10.1002/adfm.201905013
[26] CARTER K A, LUO D, RAZI A, et al. Sphingomyelin liposomes containing porphyrin-phospholipid for irinotecan chemophototherapy[J]. Theranostics,2016,6(13):2329-2336. doi:  10.7150/thno.15701